The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors

Title
The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors
Authors
Keywords
Diabetes, Cardiovascular, Randomized controlled trial, DPP-4 inhibitors, GLP-1 agonists, SGLT2 inhibitors
Journal
TRENDS IN CARDIOVASCULAR MEDICINE
Volume 27, Issue 3, Pages 194-202
Publisher
Elsevier BV
Online
2017-01-28
DOI
10.1016/j.tcm.2017.01.009

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started